Laboratory Medicine ›› 2026, Vol. 41 ›› Issue (7): 696-699.DOI: 10.3969/j.issn.1673-8640.2026.07.013
Previous Articles Next Articles
Received:2024-12-20
Revised:2025-08-09
Online:2026-07-30
Published:2026-07-23
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2026.07.013
| 项目 | 例数 | 百分比/% |
|---|---|---|
| 临床症状 | ||
| 发热 | 184 | 100.00 |
| 咽痛 | 184 | 100.00 |
| 眼睑水肿 | 112 | 60.87 |
| 颈部淋巴结肿大 | 152 | 82.81 |
| 肝脏大 | 35 | 19.02 |
| 脾脏大 | 139 | 75.54 |
| EBV相关抗体 | ||
| EBV-CA-IgM抗体阳性 | 184 | 100.00 |
| EBV-CA-IgG抗体阳性 | 178 | 96.70 |
| EBV-EA-IgG抗体阳性 | 69 | 37.50 |
| EBV-NA-IgG抗体阳性 | 0 | 0 |
| 项目 | 例数 | 百分比/% |
|---|---|---|
| 临床症状 | ||
| 发热 | 184 | 100.00 |
| 咽痛 | 184 | 100.00 |
| 眼睑水肿 | 112 | 60.87 |
| 颈部淋巴结肿大 | 152 | 82.81 |
| 肝脏大 | 35 | 19.02 |
| 脾脏大 | 139 | 75.54 |
| EBV相关抗体 | ||
| EBV-CA-IgM抗体阳性 | 184 | 100.00 |
| EBV-CA-IgG抗体阳性 | 178 | 96.70 |
| EBV-EA-IgG抗体阳性 | 69 | 37.50 |
| EBV-NA-IgG抗体阳性 | 0 | 0 |
| 组别 | 例数 | PBMC | 血浆 | |||
|---|---|---|---|---|---|---|
| 阳性/[例(%)] | 阴性/[例(%)] | 阳性/[例(%)] | 阴性/[例(%)] | |||
| IM组 | 184 | 184(100.0) | 0(0) | 62(33.7) | 122(66.3) | |
| 对照组 | 205 | 24(11.7) | 181(88.3) | 0(0) | 205(100.0) | |
| χ2值 | 303.048 | 81.962 | ||||
| P值 | <0.001 | <0.001 | ||||
| 组别 | 例数 | PBMC | 血浆 | |||
|---|---|---|---|---|---|---|
| 阳性/[例(%)] | 阴性/[例(%)] | 阳性/[例(%)] | 阴性/[例(%)] | |||
| IM组 | 184 | 184(100.0) | 0(0) | 62(33.7) | 122(66.3) | |
| 对照组 | 205 | 24(11.7) | 181(88.3) | 0(0) | 205(100.0) | |
| χ2值 | 303.048 | 81.962 | ||||
| P值 | <0.001 | <0.001 | ||||
| 组别 | 例数 | PBMC/(拷贝·mL-1) | 血浆/(拷贝·mL-1) |
|---|---|---|---|
| IM组 | 184 | 201 950(33 500,500 750) | 0(0,1 105)* |
| 对照组 | 205 | 0(0,0) | 0(0,0) |
| Z值 | -17.814 | -9.903 | |
| P值 | <0.001 | <0.001 |
| 组别 | 例数 | PBMC/(拷贝·mL-1) | 血浆/(拷贝·mL-1) |
|---|---|---|---|
| IM组 | 184 | 201 950(33 500,500 750) | 0(0,1 105)* |
| 对照组 | 205 | 0(0,0) | 0(0,0) |
| Z值 | -17.814 | -9.903 | |
| P值 | <0.001 | <0.001 |
| 组别 | 例数 | PBMC/(拷贝·mL-1) | 血浆/(拷贝·mL-1) |
|---|---|---|---|
| 肝功能正常组 | 68 | 52 790(17 245,281 950) | 0(0,0) |
| 肝功能异常组 | 116 | 257 200(54 260,927 600) | 0(0,1 657) |
| Z值 | -2.282 | -2.622 | |
| P值 | 0.023 | 0.009 |
| 组别 | 例数 | PBMC/(拷贝·mL-1) | 血浆/(拷贝·mL-1) |
|---|---|---|---|
| 肝功能正常组 | 68 | 52 790(17 245,281 950) | 0(0,0) |
| 肝功能异常组 | 116 | 257 200(54 260,927 600) | 0(0,1 657) |
| Z值 | -2.282 | -2.622 | |
| P值 | 0.023 | 0.009 |
| [1] |
Damania B, Kenney S C, Raab-traub N. Epstein-barr virus:biology and clinical disease[J]. Cell, 2022, 185:3652-3670.
DOI URL |
| [2] | 郭建巍. EB病毒感染的核酸检测:标本类型的选择[J]. 分子诊断与治疗杂志, 2016, 8(3):145-149. |
| [3] | 谢正德. 儿童EB病毒传染性单核细胞增多症临床特征及诊断标准[J]. 实用儿科临床杂志, 2007, 22(22):1759-1760. |
| [4] | 中华医学会儿科学分会感染学组, 全国儿童EB病毒感染协作组, 申昆玲. 儿童EB病毒感染相关疾病的诊断和治疗原则专家共识[J]. 中华儿科杂志, 2021, 59(11):905-911. |
| [5] |
Barrett T M, Liebert M A, Eick G N, et al. Circulating epstein-barr virus antibody levels as a biomarker of socioecological adversity in amazonian ecuador[J]. Am J Hum Biol, 2025, 37(5):e70063.
DOI URL |
| [6] |
Verougstraete N, Padalko E, Coorevits L. Interpretation of EBV serology for human body material donors:is there a need for early antigen IgG and heterophile antibodies testing?[J]. Cell Tissue Bank, 2020, 21(1):167-169.
DOI PMID |
| [7] | Yue M, Li J, Li J, et al. Comparative analysis of the immune repertoire between peripheral blood and bone marrow fluids in those infected by EBV and immunodeficiency:a retrospective case study[J]. Medicine(Baltimore), 2024, 103(38):e39501. |
| [8] | 刘春艳, 闫静, 刘亚谊, 等. EB病毒相关性传染性单核细胞增多症的血清学诊断[J]. 中华流行病学杂志, 2007, 28(9):898-900. |
| [9] |
Yan Z, Yao Z, Wang H, et al. Plasma EBV-DNA and peripheral blood mononuclear cell EBV-DNA have disparate clinical relevance in patients with extranodal NK/T-cell lymphoma[J]. J Clin Virol, 2022, 157:105320.
DOI URL |
| [10] | Zhou X, Lu X, He J, et al. Clinical value of plasma and peripheral blood mononuclear cells Epstein-Barr virus DNA dynamics on prognosis of allogeneic stem cell transplantation[J]. Front Cell Infect Microbiol, 2022, 12:1-11. |
| [11] |
Zhang W, Yin Y, Li Y, et al. Clinical utility of plasma Epstein-Barr virus DNA monitoring in pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis:a Chinese retrospective observational study[J]. Ital J Pediatr, 2024, 50(1):139.
DOI |
| [12] | 张雨涵, 李飞, 周圆圆, 等. 儿童EB病毒原发性感染血浆病毒DNA拷贝数特征[J]. 中华儿科杂志, 2023, 61(3):245-249. |
| [13] | 曾文, 麦荣嘉, 邓文喻, 等. 儿童传染性单核细胞增多症临床特点和PBMC病毒载量在预后的评估价值[J]. 现代医院, 2021, 21(7):1132-1135. |
| [14] | 晏文. 发热儿童血浆EBV DNA载量与EBV感染后相关疾病的临床特征分析[D]. 新乡: 新乡医学院, 2023. |
| [15] |
苏曦, 周琰, 沈敏娜, 等. 不同样本类型对EBV DNA检测结果的影响[J]. 检验医学, 2020, 35(8):803-805.
DOI |
| [16] | Desimio M G, Covino D A, Rivalta B, et al. The role of NK cells in EBV infection and related diseases:current understanding and hints for novel therapies[J]. Cancers(Basel), 2023, 15(6):1914. |
| [17] | Tsotridou E, Hatzipantelis E. Epstein-Barr infection,Hodgkin's lymphoma,and the immune system:insights into the molecular mechanisms facilitating immune evasion[J]. Cancers(Basel), 2025, 17(9):1481. |
| [18] |
Liu L, Yang X, Li M, et al. EBV-DNA load:a predictor of immune and hepatic dysfunction in pediatric infectious mononucleosis[J]. Diagn Microbiol Infect Dis, 2025, 113(1):116897.
DOI URL |
| [19] |
Li Y, Tang J, Ma Y, et al. Clinical significance and pathogenesis of GBP5 in infectious mononucleosis associated liver injury[J]. Ital J Pediatr, 2025, 51(1):72.
DOI PMID |
| [1] | . [J]. Laboratory Medicine, 2026, 41(5): 513-516. |
| [2] | . [J]. Laboratory Medicine, 2026, 41(3): 278-281. |
| [3] | ZHANG Chaomin, YANG Chihui, YI Changlin, LU Wenyuan. Human papillomavirus genotype analysis of different cervical lesion patients in Shanghai [J]. Laboratory Medicine, 2026, 41(2): 182-185. |
| [4] | WANG Jing, ZHANG Yifan, WANG Gang, LIN Feng, ZHANG Min, LI Xin, ZHANG Mingming, WAN Yanmin, ZHU Zhaoqin. Analysis of clinical and immunological characteristics of HIV-positive and HIV-negative monkeypox patients [J]. Laboratory Medicine, 2025, 40(12): 1139-1145. |
| [5] | WANG Chunwei, MA Xiuqing, QI Guochang, CAI Xingyao. Result analysis of nucleic acid testing in different specimen types for human cytomegalovirus [J]. Laboratory Medicine, 2025, 40(9): 881-884. |
| [6] | ZHU Jieke, ZHOU Peng, LUO Ying, WU Maofeng, XUAN Shuxia, CHEN Chen, QI Huaxin, OUYANG Yu, YIN Weiguo. Correlation of HPV combined with lower genital tract pathogen infection and cervical lesion [J]. Laboratory Medicine, 2024, 39(11): 1097-1100. |
| [7] | . [J]. Laboratory Medicine, 2024, 39(9): 908-912. |
| [8] | YAN Jianghong, WANG Le, MA Lin, YANG Shuo, GUO Weiwei, ZHAO Mengchuan, LIU Zehao, ZHAI Xiaoying. Clinical characteristics of acute lymphoblastic leukemia children infected with Epstein-Barr virus [J]. Laboratory Medicine, 2024, 39(6): 583-586. |
| [9] | WANG Xuqin, LIN Qianru, FENG Wanqing, DONG Yuan, YU Xiaolei, LIU Changhe, NING Zhen, SHEN Xin, PAN Qichao, LIN Yi. Validation of HIV-1 integrase genotyping sequence assay [J]. Laboratory Medicine, 2024, 39(4): 369-375. |
| [10] | . [J]. Laboratory Medicine, 2024, 39(1): 71-74. |
| [11] | LU Xinli, LIU Yong, LI Yan, WANG Yingying, AN Ning, LIU Meng. Identification of near full-length genome structures of new HIV-1 recombinant strains [J]. Laboratory Medicine, 2023, 38(11): 1015-1019. |
| [12] | ZHANG Yaxu, CUI Yanwei, LIU Ziyan. Preliminary research for the determination of HPV E6/E7 mRNA by nucleic acid molecular hybridization-flow cytometry [J]. Laboratory Medicine, 2023, 38(1): 46-50. |
| [13] | LIU Hongqian, SONG Chaohui, LIANG Qiaomi. Determination and quantitation of blood human papillomavirus DNA in healthy subjects [J]. Laboratory Medicine, 2021, 36(11): 1121-1124. |
| [14] | ZHANG Yunli, WANG Xin, SHAO Ling, QU Bo, ZHAO Hongmei. Comparison of different nucleic acid extraction methods for the detection of SARS-Cov-2 [J]. Laboratory Medicine, 2021, 36(5): 530-534. |
| [15] | XUAN Binbin, TAN Meiyu, SUN Hanxiao, SHENG Huiming. Mixed infection status of human papillomavirus,Ureaplasma urealyticum,Chlamydia trachomatis and Neisseria gonorrhoeae in Changning district of Shanghai [J]. Laboratory Medicine, 2020, 35(9): 859-863. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||